sábado, 18 de febrero de 2017

Imported Leptospira licerasiae Infection in Traveler Returning to Japan from Brazil - Volume 23, Number 3—March 2017 - Emerging Infectious Disease journal - CDC

Imported Leptospira licerasiae Infection in Traveler Returning to Japan from Brazil - Volume 23, Number 3—March 2017 - Emerging Infectious Disease journal - CDC

Volume 23, Number 3—March 2017

Research Letter

Imported Leptospira licerasiae Infection in Traveler Returning to Japan from Brazil

Motoyuki Tsuboi, Nobuo Koizumi, Kayoko HayakawaComments to Author , Shuzo Kanagawa, Norio Ohmagari, and Yasuyuki Kato
Author affiliations: National Center for Global Health and Medicine, Tokyo, Japan (M. Tsuboi, K. Hayakawa, S. Kanagawa, N. Ohmagari, Y. Kato)National Institute of Infectious Diseases, Tokyo (N. Koizumi)


We describe a case of intermediate leptospirosis resulting from Leptospira licerasiae infection in a traveler returning to Japan from Brazil. Intermediate leptospirosis should be included in the differential diagnosis for travelers with fever returning from South America. This case highlights the need for strategies that detect pathogenic and intermediate Leptospira species.
Leptospirosis, caused by spirochetes of the genus Leptospira, is a neglected zoonotic disease found in tropical and subtropical regions. Leptospira species are classified into 3 groups on the basis of 16S rRNA gene sequences: pathogenic, intermediate, and saprophytic groups. Although Leptospira species from the pathogenic group are considered to be the main cause of leptospirosis, Chiriboga et al. reported that most cases of leptospirosis in Ecuador were caused by intermediate species (1). We describe a case of leptospirosis caused by L. licerasiae, an intermediate species, in a traveler returning to Japan from Brazil.
In late November 2015, a previously healthy 40-year-old Japanese man sought treatment at the National Center for Global Health and Medicine (Tokyo, Japan) with a high fever and shaking chills. He had recently spent 15 days in Corumbá, Brazil, where he worked as part of a camera crew in mid-November 2015. He used insect repellent during his trip but had been bitten by mosquitoes many times while walking and swimming in waist-deep water in the Brazilian wetlands. His symptoms began 6 days after his return from Brazil and included high fever, chills, arthralgia and myalgia in his elbow and knee joints, and burning skin pain over the his whole body for the 24 hours before he sought treatment. At the time of his first visit to this clinic, he reported new onset retroorbital pain and shaking chills.
On examination, his body temperature was 39.5°C and his pulse rate was relatively low (87 beats/min). He had mild congested bulbar conjunctivae, localized urticaria on his trunk, and many small, old injury scars on both of his legs (Technical Appendix[PDF - 292 KB - 3 pages] Figure 1). Results of rapid antigen detection tests and Giemsa stains of blood smears for Plasmodium spp. were negative for 3 consecutive days. Results of laboratory tests were negative, including IgM, IgG, and NS-1 antigen tests against dengue virus; HIV screening; rapid antigen detection test against influenza virus; and blood and urine cultures. Moreover, PCR results for Leptospira and for dengue, chikungunya, and Zika viruses were negative.
Treatment with ceftriaxone (2 g 1×/d) was initiated 1 day after hospital admission. Four hours after infusion began, the patient’s fever rose to 40°C, which was considered a Jarisch-Herxheimer reaction. Fever resolved the next day. Laboratory test results showed elevated total bilirubin (2.3 mg/dL [reference range 0.3–1.2mg/dL]), aspartate aminotransferase (62 U/L [13–33 U/L]), alanine aminotransferase (73 U/L [8–42 U/L]), lactic acid dehydrogenase (456 U/L [119–229]), and C-reactive protein (13.6 mg/dL [0–0.3 mg/dL]), but these values quickly returned to within reference ranges. Three days after ceftriaxone treatment began, all symptoms had resolved, and the patient was discharged from the hospital with a prescription for doxycycline (100 mg 2×/d).
At the time of discharge, 3 days after the blood culture was set up, spirochetes were observed in Korthof and EMJH media. Nucleotide sequencing of the 16S rRNA gene of the isolate, NIID18 (Japan National Bioresource of Bacterial Pathogens no. 18467, http://pathogenic.lab.nig.ac.jp/) (Technical Appendix[PDF - 292 KB - 3 pages]Figure 2), revealed it to be Llicerasiae: the sequence (GenBank accession no. LC164227) had 99.3% identity (1,339/1,348 bp) with VAR 010 (GenBank accession no. EF612284), the type strain of L. licerasiae. The partial flaB sequence of the NIID18 isolate (GenBank accession no. LC164228) also showed the highest similarity with VAR 010 (96.6%, GenBank accession no. LC005426). NIID18 did not react with a panel of antisera for 18 serovars (2). An increase in antibody titers in paired serum samples was observed against the isolate (reciprocal titers 50 and 200 in acute- and convalescent-phase samples, respectively), according to microscopic agglutination test (3). After receiving antimicrobial drug therapy for 7 days, the patient had completely recovered.
The intermediate Leptospira group comprises 5 species: L. licerasiaeL. wolffiiL. faineiL. broomii, and L. inadai. Although this species group has been detected in environmental soil and water samples from the Southeast Asia (46), human cases involving returned travelers have not been well-documented previously (1,710). To our knowledge, only 2 cases of L. licerasiae isolation from a human host have been reported; such isolations were first reported in Peru in 2008 (7) (Table), although many serum samples from febrile patients in the Peruvian Amazon have reacted with an L. licerasiae isolate. Members of Rattus species are considered major reservoir hosts (7).
We were unable to detect Leptospira DNA in the case-patient’s blood using flaB-nested PCR because this method is specific to species in the pathogenic group. The patient received a diagnosis of leptospirosis after L. licerasiae was isolated from a blood culture. Therefore, PCR targeting conserved genes among genus Leptospira, such as 16S rRNA, is more suitable not only for clinical situations but also for epidemiologic studies.
This case highlights the need for including leptospirosis caused by intermediate group species in the differential diagnosis for patients with fever who have recently returned from South America. In addition, we emphasize the utility of genes such as 16S rRNA for detecting pathogenic and intermediate Leptospira groups.
Dr. Tsuboi is an infectious diseases fellow at the Disease Control and Prevention Center in the National Center for Global Health and Medicine, Tokyo, Japan. His primary research interests are travel medicine and sexually transmitted infections.


We thank the clinical staff at the Disease Control and Prevention Center, Japan, for their help in the completion of this study.
This study was supported in part by the Emerging/Re-emerging Infectious Diseases Project of Japan from Japan Agency for Medical Research and Development (16fk0108046h0003).


  1. Chiriboga JBarragan VArroyo GSosa ABirdsell DNEspaña Ket al. High prevalence of intermediate Leptospira spp. DNA in febrile humans from urban and rural Ecuador. Emerg Infect Dis2015;21:21417.
  2. Koizumi NMuto MMAkachi SOkano SYamamoto SHorikawa Ket al. Molecular and serological investigation of Leptospira and leptospirosis in dogs in Japan. J Med Microbiol2013;62:6306.
  3. Koizumi NMuto MYamamoto SBaba YKudo MTamae Yet al. Investigation of reservoir animals of Leptospira in the northern part of Miyazaki Prefecture. Jpn J Infect Dis2008;61:4658.
  4. Azali MAYean Yean CHarun AAminuddin Baki NNIsmail N. Molecular characterization of Leptospira spp. in environmental samples from North-Eastern Malaysia revealed a pathogenic strain, Leptospira alstonii. J Trop Med. 2016;2016:2060241.
  5. Saito MVillanueva SYChakraborty AMiyahara SSegawa TAsoh Tet al. Comparative analysis of Leptospira strains isolated from environmental soil and water in the Philippines and Japan. Appl Environ Microbiol2013;79:6019.
  6. Thaipadungpanit JWuthiekanun VChantratita NYimsamran SAmornchai PBoonsilp Set al. Leptospira species in floodwater during the 2011 floods in the Bangkok Metropolitan Region, Thailand. Am J Trop Med Hyg2013;89:7946.
  7. Matthias MARicaldi JNCespedes MDiaz MMGalloway RLSaito Met al. Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis2008;2:e213.
  8. Slack ATKalambaheti TSymonds MLDohnt MFGalloway RLSteigerwalt AGet al. Leptospira wolffii sp. nov., isolated from a human with suspected leptospirosis in Thailand. Int J Syst Evol Microbiol2008;58:23058.
  9. Levett PNMorey REGalloway RLSteigerwalt AGLeptospira broomii sp. nov., isolated from humans with leptospirosis. Int J Syst Evol Microbiol2006;56:6713.
  10. Schmid GPSteere ACKornblatt ANKaufmann AFMoss CWJohnson RCet al. Newly recognized Leptospira species (“Leptospira inadai” serovar lyme) isolated from human skin. J Clin Microbiol1986;24:4846.


Technical Appendix

Cite This Article

DOI: 10.3201/eid2303.161262

No hay comentarios:

Publicar un comentario